Bio Asia 2026 | Bio Asia 2026 Summit - Telangana Life Sciences

Event Info + Theme Intro

Life sciences

Pharmaceuticals

MedTech

Health Tech/Healthcare

In an era marked by unprecedented global health challenges, the urgency for innovation, collaboration, and accelerated transformation in healthcare has never been greater.

BioAsia 2026 returns to Hyderabad for its 23rd edition, bringing together global leaders from industry, academia, government, and regulatory agencies. Together, they will showcase breakthrough advancements across biopharma, medtech, digital health, and AI-driven technologies shaping the future of healthcare.

As Asia's foremost life sciences and healthcare event, BioAsia 2026 offers an unparalleled platform for fostering global partnerships, attracting investments, and accelerating meaningful progress toward a healthier world.

0+

Participants

0+

Partnering Meetings

0+

Corporates

0+

High Profile Speaker

0+

Countries

Past Speakers

Robert Bradway

Chairman & CEO, Amgen

Mr. Dave Williams

EVP, Chief Information & Digital Officer MSD

Dr. S. Somanath

Ex-Chairman, ISRO

Mr. Bill Gates

Co-Chair, Bill & Melinda - Gates Foundation

Mr. Shri Piyush Goyal

Union Minister of Commerce & Industry, India

Dr. Vas Narasimhan

CEO, Novartis

Dr. Soumya Swaminathan

CHIEF SCIENTIST, WHO

Mr. Paul Polman

FORMER CEO,UNILEVER

Dr. Toon Overstijns

CEO, Miltenyi Biomedicine GmBH

Ken Washington

CTO, Medtronic

Mr. Amitabh Kant

India’s G20 Sherpa

Mr. Satya N Nadella

CEO, Microsoft

Dr. Boris Stoffel

Managing Director, Milteny iBiotec B.V. & Co.KG

Mr. Alex Gorsky

Executive Chairman

Dr. Carl June

CAR T-CELL THERAPY PIONEER, USA

Dr. Christopher Boerner

CEO, Bristol Myers Squibb

Mr. David Ricks

CEO, Eli Lilly and Company

Mr. Geoff Martha

Chairman and CEO, Medtronic

Prof. Gregg Semenza

Nobel Laureate & Professor at Johns Hopkins School of Medicine

Mr. Rod Hochman MD

CEO, Providence

Mr. Stefan Kaufmann

CEO, Olympus

Dr. Seth Berkley

CEO, GaviAlliance

Day 1

17th February 2026

09:30 - 10:00

Inauguration of International Exhibition

10:00 - 11:00

Inaugural Ceremony

1. Sri. A. Revanth Reddy, Hon’ble Chief Minister of Telangana
2. Sri. D. Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana
3. Sri. Sanjay Kumar (IAS), Special Chief Secretary, Industries & Commerce, Government of Telangana

11:00 - 11:20

Keynote Address

11:20 - 11:40

Keynote Address

Dr. Howard Y. Chang, Chief Scientific Officer and SVP Global Research, Amgen, USA

11:45 - 12:45

Session Sponsor: EY Panel Discussion

Catalysts that Actually Scale: Science, Software & Supply Not every breakthrough changes the world. This discussion explores what it really takes to scale - blending cutting-edge science, digital technologies, and resilient supply chains to move innovation from lab bench to bedside.

Speakers:
1. Mr. Eamonn Warren, Group VP, Manufacturing (API & Dry Products), Lilly Global, USA
2. Dr. Despina Solomonidou, EVP, Global Head Technical Research & Development, Novartis, Switzerland
3. Ms. Rashmi Kumar, SVP & Chief Information Officer, Medtronic, USA
4. Dr. Peter Owotoki, Cofounder & CEO, EmpathicAI.life Ltd, Germany
5. Prof. Kil To Chong, Founder & CEO, JuYoungBio Corporation, South Korea
6. Dr. Kenneth Barr, SVP, Head of Strategic Collaborations, Head of SynVent, Syngene

Moderator: Mr. Daniel Mathews, EY Global and EMEIA Life Sciences Sector Lead, UK

12:45 - 14:00

Networking Lunch & Visit to Exhibition

14:00 - 15:00

Session Sponsor: EY Panel Discussion

From Headwinds to Health Wins: Where Growth Will Come From (’26–’30) Pharma and biotech CEOs dissect growth headwinds - pricing pressure, regulatory shifts, talent shortages - and reveal the growth engines they’re betting on for the next five years.

Speakers:
1. Dr. Peter Piot
2. Dr. Krishna Prasad Chigurupati, Chairman & MD, Granules
3. Mr. Vikrant Shrotriya, MD, Novo Nordisk India
4. Mr. Giuliano Perfetti, CEO & MD, Jubilant Biosys Limited
5. Mr. Srinath Venkatesh, MD, India and South Asia, Thermo Fisher Scientific
6. Mr. Amit Mookim, CEO, Immuneel Therapeutics Private Limited

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY India

15:05 - 15:20

Plenary Address

Mr. Pushmeet Kohli, VP of Science, Google DeepMind, UK

15:25 - 16:25

Panel Discussion

Next-Gen Biologics & Advanced Modalities: From Discovery to Clinical Proof & CMC at Scale The panel will discuss how next-generation biologics and advanced modalities, including cell & gene therapies, mRNA, and radiopharmaceuticals, are progressing from discovery to clinical proof and scalable CMC, with generative AI and advanced computational tools increasingly supporting decisions across target design, process development, analytics, and manufacturing readiness.

Keynote Address: Dr. Stefan Miltenyi, Founder & President, Miltenyi Biotec, Germany

Speakers:
1. Dr. Raches Ella, Chief Development Officer, Bharat Biotech
2. Dr. Darrin Morrissey, CEO, NIBRT, Ireland
3. Dr. Sangita Reddy, Joint MD, Apollo Hospitals Group
4. Dr. José Castillo, CEO, Quantoom Biosciences, Belgium

Moderator: Mr. Gil Bashe, Chair Global Health and Purpose, FINN Partners, USA

16:30 - 17:30

Session Sponsor: BCG Panel Discussion

CRDMO 2.0: AI as a Force Multiplier Across the Value Chain As CRDMOs scale globally, they face increasing pressure to deliver faster execution, higher operational efficiency, and more personalised customer engagement. This session will explore how AI can act as a force multiplier, enhancing operational excellence, improving decision-making, and enabling strategic differentiation across the CRDMO value chain.

Speakers:
1. Dr. Satyanarayana Chava, Founder and CEO, Laurus Labs
2. Dr. Matthew Moorcroft, SVP, Global Marketing & Intelligence, Lonza, UK
3. Mr. Manni Kantipudi, CEO, Aragen Lifesciences
4. Mr. Krishna Kanumuri, MD & CEO, Sai Lifesciences

Moderator: Mr. Vikash Agarwalla, MD & Partner, BCG

17:30 - 18:00

Networking break and visit to the International Exhibition

18:00 - 19:15

Session Sponsor: Oliver Wyman CEO Conclave

Future of Pharma & Biotech (’26-’30): Growth, Headwinds & Opportunities A marquee BioAsia tradition, global CEOs in a no-holds-barred conversation about what the industry will look like by 2030. Growth, innovation, geopolitics, and resilience - all on the table.

Speakers:
1. Mr. Amitabh Kant, Former G20 Sherpa, Government of India
2. Mr. G. V. Prasad, Co-Chairman & MD, Dr. Reddy’s Laboratories
3. Mr. Eric Mansion, GM, India & South-East Asia, Sanofi, Singapore
4. Mr. Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Limited
5. Mr. Shreehas Tambe, MD and CEO, Biocon Biologics
6. Dr. Toon Overstijns, CEO & Board Member, Milteyni Biotec, Belgium
7. Mr. Winselow Tucker, President and GM, Lilly India

Moderator: Ms. Ekta Batra, Editor, Pharmaceuticals and Healthcare, CNBC TV18

19:15 Hrs

Networking Reception

Day 2

18th February 2026

11:00 - 11:15

Plenary Address

Ms. Madeleine Roach, EVP, Head of Business Operations, Sanofi, France

11:20 - 12:20

Session Sponsor: Healthark Panel Discussion

Building Innovation-First GCCs: AI, R&D & Digital Transformation This session explores the next generation of life sciences GCCs, which are being built around intelligence, innovation, and integration. As GCCs evolve from cost centres into strategic growth engines, the panel examines how AI-enabled R&D, modern digital architectures, and new operating models are repositioning them as core contributors to global innovation strategies.

Opening Keynote: Mr. Anton Groom, Chief AI Officer, MSD, USA

Speakers:
1. Mr. Badhri Srinivasan, Group CEO, Unilabs, Switzerland
2. Mr. Syed Naveed, Executive Officer & CTO, Olympus Corporation, Japan
3. Mr. Sanjay Patel, SVP & Global Head of Innovation Capability Solutions & Services, Takeda, Switzerland
4. Mr. Som Chattopadhyay, SVP, Global Business Solutions and National Executive, Amgen, USA
5. Ms. Gail Horwood, Chief Marketing and Customer Experience Officer, Novartis, USA

Moderator: Dr. Purav Gandhi, Founder & CEO, Healthark

12:25 - 13:25

Session Sponsor: KPMG Panel Discussion

Making It Matter: How GCCs Transform Capability into End-Patient Impact This session intends to showcase the impact and outcomes enabled by Healthcare GCCs on what matters: the end-patient. GCC capabilities have evolved greatly over the years, and KPMG will enable conversations with senior Healthcare leaders to understand the far-reaching impact of Healthcare GCCs. During this session, KPMG will also release a whitepaper curating key patient-impact narratives from select Healthcare GCC organisations.

Speakers:
1. Ms. Siva Kumar Padmanabhan, MD & Head of Global Innovation & Technology Centre, AstraZeneca
2. Ms. Chandani Palshetkar, Global Head of Strategy, Hub & Services, Opella Healthcare
3. Dr. Anand Jain, Vice President, Product & Portfolio Strategy, Novo Nordisk
4. Mr. Manish Arora, Associate VP & General Manager, Eli Lilly Services
5. Mr. Mahesh Natarajan, Senior Director, Thermo Fisher Scientific
6. Mr. Srinivas Peddi, Senior Director & Centre Head, Becton Dickinson Technology Campus

Moderator: Ms. Shalini Pillay, Partner at KPMG and India leader, GCC

13:25 - 14:25

Networking Lunch & Visit to Exhibition

14:25 - 15:25

Session Sponsor: BMS Panel Discussion

India’s Innovation Moment: Scaling the Next Phase of Global Impact India’s innovation landscape is expanding rapidly, yet challenges in funding, talent, and commercialization continue to shape the pace of progress. This session explores where India stands today, and what it will take to accelerate impact at scale.

Speakers:
1. Ms. Preeti Sudan IAS (Retd.), Former Chairperson, UPSC and Former Union Health Secretary, Government of India
2. Mr. Sridhar Gopal, Head of International Business Development, AbbVie, USA
3. Mr. Nataraj Kalyanaraman, VP, Head of Drug Development, BMS
4. Mr. Vikas Jain, VP & Head of Life Sciences, TCS
5. Mr. Raja Jammalamadaka, Head, Roche Digital Centre
6. Mr. Greg Killian, SVP & GM, Global Life Sciences & Healthcare, EPAM Systems, USA

Moderator: Mr. Vikas Dandekar, Editor (Pharma & Healthcare), The Economic Times

15:30 - 16:10

Panel Discussion

Financing TechBio & DeepTech Manufacturing Deep tech and advanced biotech are often seen as high-risk, but global success stories show the potential. Join this panel of leading VCs as they share what investors look for, how to de-risk innovation, and the opportunities for scaling breakthrough technologies in India for the world.

Speakers:
1. Mr. Charles Janssen, Managing Partner, HealthKois, Belgium
2. Mr. Karthik Narayanaswamy, Partner & Head of India, Novo Holdings
3. Mr. Sunil Thakur, Partner, Quadria Capital & Co-founder, HealthQuad, Singapore
4. Dr. Ramesh Byrappaneni, Managing Director, Endiya Partners

16:15 - 16:30

TELANGANA RISING 2047: BUILDING A WORLD-CLASS LIFE-SCIENCES ECOSYSTEM

Fireside Chat: Sri. D. Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana

16:35 - 17:00

Valedictory and Startup Awards Ceremony